VYGR- Voyager Therapeutics, Inc.

Name: Voyager Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Sandrock Alfred	484.1K	$2.01M	-
COO	Swartz Robin	199.7K	$828.9K	-
Other	Ferguson Toby	183.9K	$763.2K	-
CFO	Jorgensen Nathan D.	151.4K	$628.4K	-
Other	Carter Todd Alfred	145.7K	$604.7K	-

Activity

Buys and sells only

Transactions

10 filings · page 8

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Apr 5, 2021	Hesslein Robert W.49	Senior VP &General Counsel	Sell	3,292	$4.95	$16,295.40	-2.9%	-22.8%	+78.4%
Feb 11, 2021	Turenne Andre	President &CEO	Sell	7,977	$7.55	$60,226.35	-5.1%	-	-
Feb 11, 2021	Dorval Allison	Chief Financial Officer	Sell	3,186	$7.55	$24,054.30	-6.5%	-	-
Feb 11, 2021	Hesslein Robert W.49	Senior VP &General Counsel	Sell	3,186	$7.55	$24,054.30	-6.1%	-	-
Feb 11, 2021	Khwaja Omar	See Remarks	Sell	3,475	$7.55	$26,236.25	-6.2%	-	-
Jan 12, 2021	Turenne Andre	President &CEO	Sell	10,443	$8.62	$90,018.66	-6.3%	-	-
Jan 12, 2021	Dorval Allison	Chief Financial Officer	Sell	2,942	$8.62	$25,360.04	-5.7%	-	-
May 21, 2020	Khwaja Omar	See Remarks	Sell	3,500	$12.96	$45,360.00	-5.8%	-	-
Apr 3, 2020	Hesslein Robert W.49	Senior VP &General Counsel	Sell	3,091	$8.51	$26,304.41	-5.6%	-	-
Jan 21, 2020	Dorval Allison	Chief Financial Officer	Sell	3,128	$13.36	$41,790.08	-11.3%	-	-

← PrevPage 8Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC